Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual Sufentanil for Recovery in Ambulatory Knee Arthroscopy
NCT04561375Phase 4Terminated
- Sponsor
- Cleveland Clinic
- Start
- Dec 2020
- Primary completion
- Jul 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of SurBred in postoperative pain (2 arms), sponsored by Cleveland Clinic. Primary endpoint: Total Consumption of Fentanyl at 3 hours. Started Dec 2020; status: terminated.
02
Drugs
SurBred
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04561375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04561375.